Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 10mg dose of tirzepatide (Mounjaro) equals 10 units on a standard insulin syringe marked in milligrams — because Mounjaro's KwikPen delivers a fixed volume, not a unit count that you measure yourself. Each pre-filled pen contains four 0.5ml doses, each pre-set to the labelled strength, so the 10mg pen gives exactly 10mg per weekly injection without any measuring on your part. That said, if you've seen unit values mentioned online and want to understand what they actually mean for this particular dose, the short answer is that tirzepatide is not drawn up in units the way insulin is — the pen does the maths. For anyone working out what 10mg tirzepatide looks like in unit terms, it helps to understand how the KwikPen system works, and why the comparison to insulin units is often misleading. These are prescription-only medicines; a GPhC-registered prescriber decides the right dose for each person after a full clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people asking this have experience with insulin, or they've seen compounded or unlicensed tirzepatide sold in vials online, where a syringe and unit markings are involved. It's a fair question, and an important safety one. Insulin syringes use a unit scale that has no direct equivalence to milligrams of tirzepatide, so converting between units and milligrams, even at a dose like 5mg, is not a straightforward calculation. The licensed Mounjaro KwikPen sidesteps all of this by delivering a pre-measured, fixed volume at the push of a button. You press, you hear the click, the dose is done.
If you're trying to understand the maths behind vial-based tirzepatide, it's worth knowing that unlicensed vials are not part of the authorised UK supply chain, and the MHRA has warned explicitly about the risks of tirzepatide sold outside that chain, including fake pens and unverified vials seized in large enforcement operations. Our FAQs cover the supply chain question in more detail.
For the licensed KwikPen, there is no unit conversion to do. The pen is set. That's the point of the design.
The 10mg dose sits in the upper-middle of Mounjaro's licensed range. In the SURMOUNT-1 trial (a 72-week study in over 2,500 adults with obesity, published in the New England Journal of Medicine) participants at the 10mg maintenance dose achieved meaningful average weight loss, with the 15mg group reaching approximately 20–21% average reduction overall. The 10mg dose produced substantial results in its own right, though individual outcomes varied considerably depending on adherence, lifestyle factors and starting weight.
What the trial also confirmed is that the dose progression matters. Participants started at 2.5mg (a level designed to let the body adjust rather than to produce weight loss) and moved upward in steps. Jumping straight to 10mg would have produced significantly more gastrointestinal side effects with no additional long-term benefit. The 5mg dose typically comes before 10mg in the titration sequence, and the prescriber decides the timing of each step based on how a person is tolerating the current dose.
NICE's appraisal of tirzepatide (TA1026) drew on this trial evidence when recommending the medicine for eligible adults on the NHS. The recommendation covers the full licensed range, not a specific dose, because the right maintenance dose is an individual clinical decision.
Each Mounjaro KwikPen contains four weekly doses. When you press the button, a fixed 0.5ml volume is injected subcutaneously, into the abdomen, thigh or upper arm, rotating sites each week. The concentration in each pen varies by strength so that the same 0.5ml always delivers the labelled milligram amount. At 10mg, that means 10mg every time, with no variation based on how you hold the pen or how quickly you inject.
For anyone curious about how this compares at other points on the titration ladder, the 7.5mg dose follows the same fixed-volume principle, as does every other strength. The pen cannot be partially depressed to give a smaller dose, and it is not designed to be emptied into a syringe. Attempting to do so would compromise sterility and almost certainly introduce dosing error.
If you want a fuller look at the general Mounjaro dose and treatment pathway, our Mounjaro overview covers the whole picture in plain language.
Reaching 10mg means a person has already been on treatment for roughly 12 to 16 weeks. By this point, a prescriber reviewing your case (as happens at every repeat with a regulated online pharmacy) will be looking at how much weight has been lost, how the previous doses were tolerated, and whether there are any clinical reasons to pause titration rather than continue upward.
We know from the trial data and from NHS guidance on tirzepatide that gastrointestinal effects (nausea most commonly, sometimes vomiting or diarrhoea) tend to be most noticeable after a dose increase and often settle within a few weeks. At 10mg, some people find the GI effects more pronounced than at earlier steps; others tolerate it easily. The prescriber's job is to weigh that against the progression plan.
If you're wondering where you sit in that picture, or whether 10mg is the right next step for you, that's precisely the conversation a clinical review is for. The free consultation at nume is reviewed the same day by a named GPhC-registered prescriber, a real clinician, not an automated decision. We know that working out dosage questions online can feel frustrating when what you actually need is a direct answer from someone who knows your case. That's what the consultation is there for.
For broader context on how treatment costs sit alongside the clinical process, our Mounjaro pricing page explains what's included in a single transparent price.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.